Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim
source: shutterstock.com

Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim

Clinical-stage biopharmaceutical company Savara Inc. was founded on a desire to develop innovative therapies for people living with rare respiratory diseases. The company's work over the past few years centers…

Continue Reading Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim